IVKSX | VIVIX | IVKSX / VIVIX | |
Total Expense Ratio | 0.95 | 0.04 | 2,375% |
Annual Report Gross Expense Ratio | 1.05 | 0.04 | 2,625% |
Fund Existence | 23 years | 27 years | - |
Gain YTD | -1.379 | 10.260 | -13% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 232M | 203B | 0% |
Annual Yield % from dividends | 1.64 | 2.11 | 77% |
Returns for 1 year | -0.85 | 7.68 | -11% |
Returns for 3 years | 15.48 | 50.25 | 31% |
Returns for 5 years | 66.77 | 81.82 | 82% |
Returns for 10 years | 68.31 | 147.68 | 46% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ESCKX | 16.32 | 0.19 | +1.18% |
1290 Essex Small Cap Growth R | |||
TCIEX | 27.43 | 0.23 | +0.85% |
Nuveen International Eq Idx R6 | |||
GSAHX | 16.57 | 0.11 | +0.67% |
Goldman Sachs Small Cap Growth Investor | |||
MALRX | 24.08 | 0.14 | +0.58% |
BlackRock Advantage Large Cap Core Instl | |||
MTOIX | 22.61 | 0.09 | +0.40% |
NYLI Income Builder Class I |